Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 8, 2023, the Company appointed Dr.. | May 11, 2023
Company successfully submits GTX-104 Pivotal Phase 3 protocol IND amendment to the FDA with expectation for first patient dosed in calendar Q4 2023
Strategic realignment prioritizes GTX-104 and. | May 8, 2023